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Rhomboencephalitis – inflammation of the brainstem and cerebellum – has myriad clinical 
presentations including encephalopathy, cranial neuropathies, long tract signs and cerebellar 
dysfunction, and is associated with significant morbidity and mortality. There are a variety of 
potential underlying aetiologies which are variably responsive to treatment including infections, 
para-infectious syndromes, inflammatory disorders including autoimmune encephalitis and 
paraneoplastic syndromes.  
This review provides an overview of the clinical presentation of rhomboencephalitis together with 
an outline of a practical approach to its investigation with the aim of facilitating prompt diagnosis 
and confirmation of the underlying cause with early instigation of appropriate management and 




The name rhombencephalon derives from the Greek for “rhombus” meaning diamond-shaped 
structure and “enkephalos” referring to the brain. It comprises both the metencephalon and 
myelencephalon of the hindbrain. The metencephalon includes the cerebellum, the pons with its 
adjacent fourth ventricle and cranial nerves V-VIII. The myelencephalon contains the medulla 
oblongata with its fourth ventricle counterpart along with the bulbar cranial nerves and a portion of 
the vestibulocochlear nerve (Figure 1). 
 
Despite the rhombencephalon technically excluding the midbrain, the term rhomboencephalitis 
(also known as rhombencephalitis) is often used interchangeably with brainstem encephalitis and, 
for practical purposes, we will include brainstem encephalitis in our discussion of 
rhomboencephalitis. 
Aetiology 
We searched MEDLINE (1946 – December 2019) and EMBASE (1974 – December 2019), with no 
limits to language, and identified all the documented causative agents of rhomboencephalitis. We 
used the primary search terms “rhomboencephalitis”, “rhombencephalitis” and “brainstem 
encephalitis” including their synonyms, individually or in combination, to yield a search result of 
1787 papers. These were then reviewed, and paediatric cases were excluded. The reported causes of 




Table 1 - Causes of brainstem encephalitis   




Borrelia burgdorferi Uncommon 
Mycoplasma Uncommon 




Brucellosis  Rare 




Herpes simplex virus-1 and -2 Common 
Enterovirus 71 Common in children, uncommon in adults 
Epstein-Barr virus Uncommon 
Cytomegalovirus Uncommon 
Japanese Encephalitis Common in children, uncommon in adults 
Enterovirus D68 Uncommon 
Coxsackie A16  Uncommon 
SARS-CoV-2 Rare  
Coxsackie B3 Rare 
Varicella zoster virus Rare 
Human herpes virus-6 Rare 
Adenovirus Rare 
Mumps Rare 
Hepatitis E Rare 
Rabies virus Rare 
Human parechovirus Rare 
West Nile virus Rare 
Eastern equine virus encephalitis Rare 
St Louis Encephalitis Rare 
Dengue Fever Rare 
Chandipura vesiculovirus Rare 
 
Fungal  







Inflammatory   
Neuro-Behçet's syndrome Common 
Systemic lupus erythematosus Uncommon 
Sjogren's syndrome Rare 
Relapsing polychondritis Rare 
Sarcoidosis Rare 
Paraneoplastic   









Cell surface antibody   
Anti-MOG Common 
Anti-NMDA receptor encephalitis Uncommon 
Anti-IgLON5 receptor encephalitis Uncommon 
Anti-glycine receptor encephalitis Uncommon 
GABAb receptor encephalitis Rare 
Anti-DPPX receptor encephalitis Rare 
Voltage-gated calcium channel antibodies Rare 
Anti-aquaporin-4 antibodies (AQP-4, NMO) Rare 
Others   
Bickerstaff's brainstem encephalitis Common 
Acute disseminated encephalomyelitis  Uncommon 
Immune checkpoint inhibitor-induced (e.g. pembrolizumab 
and nivolumab) Uncommon 
Vogt-Koyanagi-Harada  Rare 
Kikuchi-Fujimoto disease  Rare 
Anti-SRP antibodies Association in 2 cases found 
DPPX = dipeptidyl-peptidase–like protein 6, GABA = Gamma aminobutyric acid, GAD = glutamic acid 
decarboxylase, IgLON5 = immunoglobulin-like cell adhesion molecule 5, MOG = myelin oligodendrocyte 






Infectious rhomboencephalitides are typically bacterial or viral. Although more frequently reported 






The most common cause of rhomboencephalitis is infection with the Gram-positive bacteria Listeria 
monocytogenes. Public Health England recorded 135 cases of listeriosis in the UK in 2017. The 
bacterium is present in soil and vegetation and 1-5% of the population are asymptomatic carriers. 
Outbreaks have been associated with contamination of unpasteurised cheeses or milks, cured 
meats, pâtés, smoked fish, cooked shellfish and, rarely, pre-packed salads, particularly if mixed with 
meat. Brainstem infection is thought to occur due to retrograde axonal translocation via the cranial 
nerves innervating the oropharynx.  It can also occur opportunistically in skull base erosion typically 
associated with cocaine abuse.1 
Although listeriosis can affect the immunocompetent, it typically presents in the elderly, 
immunocompromised or pregnant population, manifesting as meningitis or meningoencephalitis. 
The risk appears to be particularly high with infliximab (anti-tumour necrosis factor-α); first year risk 
estimated at 4.3-15.5 cases per 100,000.2 The source of infection may be from contaminated food 
consumption or chronic faecal carriage, although the predilection for the complication to occur early 
in treatment, may favour re-emergence of latent disease and patients on anti-TNF-α blockers should 
be advised to take additional precautions with food hygiene e.g. avoidance of raw or undercooked 
eggs, pate, meat and poultry as well as unpasteurised dairy products or soft and blue cheeses 
 
Rhomboencephalitis occurs in approximately 9% CNS listeria infections (Figure 2) and can occur in 
immunocompetent individuals. Of particular note for neurologists, cases have also been reported in 
association with disease modifying treatment for multiple sclerosis.3 4 Traditionally, it begins with a 
biphasic ‘flu-like illness followed, over a period of days, by the emergence of encephalopathy and 
brainstem signs. Magnetic resonance imaging (MRI) of the brain may demonstrate multifocal 
abscesses e.g. T2-hyperintensities or ring-enhancing lesions on post-contrast T1-sequences found in 
the thalamus, pons, medulla and cerebellar peduncles (Figure 2).5 Diagnosis is confirmed by culture 
of the organism from blood or cerebrospinal fluid (CSF) although CSF polymerase chain reaction 
(PCR) has greater sensitivity. There are limited data to support brain biopsy in cases of diagnostic 
uncertainty.  
The importance of early recognition and initiation of appropriate treatment is highlighted by 
mortality rates; 100% for untreated listeria rhomboencephalitis, falling to 76% with suboptimal 
antimicrobials and 40% with targeted therapy e.g. intravenous amoxicillin or ampicillin 2g every four 
hours ± gentamicin or co-trimoxazole. Abscess formation may necessitate longer duration of 
treatment and development of hydrocephalus or intraventricular haemorrhage, which occur in 10-
15% and 5% cases respectively, necessitate consideration of neurosurgical intervention.6 




CNS involvement occurs in approximately 10% patients with tuberculosis (TB), and approximately 5% 
of these have brainstem disease.  Caseating granulomata can mimic bacterial abscesses and tumour 
necrosis on neuroimaging, although core T2-hypointensity with vivid peripheral contrast 
enhancement on MRI representing gliosis and monocyte invasion are suggestive.7  
TB diagnosis is confirmed through detection of acid-fast bacilli e.g. in respiratory samples, early 
morning urine or biopsy of tuberculoma. CSF culture and staining have sensitivities of <20%, 
although this increases with repeated sampling.  Larger CSF volumes may also increase the 
diagnostic yield. CSF adenosine deaminase (ADA), a marker of cell-mediated immunity, has reported 
sensitivities and specificities between 44-100% and 71-100% respectively.7 Given the significant 
morbidity and mortality, treatment for CNS involvement should be initiated if the clinical findings 
and investigation results are consistent with the diagnosis even if a rapid diagnostic test has 
returned negative results.8 
NICE recommends CNS TB treatment that includes rifampicin, isoniazid (with pyridoxine), 
pyrazinamide and ethambutol for 2 months, followed by 10 months of rifampicin and isoniazid (with 
pyridoxine).8 High dose corticosteroids are recommended with initiation of treatment with 
subsequent taper over 4-8 weeks. Neurosurgical management is typically reserved for complications 
such as hydrocephalus, reducing mass effect due to tuberculomas and abscess drainage.   
Neuroborreliosis 
 
Lyme disease has protean CNS manifestations including lymphocytic meningitis, cranial neuropathies 
or a painful radiculitis 4-6 weeks after tick exposure.  An index of clinical suspicion is required 
because only half of patients with neuroborreliosis report a rash consistent with erythema migrans 
and one quarter recall a tick bite. Serology (serum and CSF if rhomboencephalitis suspected) is 
recommended with input from a reference laboratory for extended immunoblotting if results are 
positive or equivocal. Interval serological testing e.g. at 4 weeks can also be performed if tests are 
non-corroborative and there is ongoing clinical suspicion.  CSF lymphocytosis is present in virtually 
all cases. Parenchymal brain changes are rare in neuroborreliosis but there are reports of pontine 
and cerebellar peduncle involvement. Treatment of Lyme disease affecting the CNS is with 4g total 
intravenous ceftriaxone daily for 21 days, whilst observing for a Jarisch-Herxheimer reaction which 
can occur 1-12 hours following initiation of therapy. 
Viral 
Herpes Simplex Virus-1 and Herpes Simplex Virus-2 (HSV-1 and HSV-2) 
 
HSV encephalitis (HSVE) is the commonest form of sporadic encephalitis and neurological 
involvement typically causes temporal lobe, insular cortex, orbital frontal lobe and angular gyrus 
inflammation with sparing of the basal ganglia and lobar white matter. More rarely, it can lead to 
rhomboencephalitis and, when this does occur, 80% are attributable to the HSV-1 subtype.9 
Retrograde spread is thought to occur from the cisternal portion of the trigeminal ganglion into the 
brainstem and the radiological presentation may mimic an underlying neoplasm.  Those with 
rhomboencephalitis may have isolated brainstem MRI changes although approximately 50% have 
concomitant supratentorial lesions,10 and the diagnosis is usually confirmed on CSF PCR. Treatment 
is with intravenous acyclovir (10mg/kg three times per day) for a minimum of two weeks and current 
UK guidelines recommend repeat CSF analysis to confirm HSV PCR negative prior to discontinuation 




Coronavirus disease-2019 (COVID-19) is caused by the newly identified severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2). It is known that SARS-CoV-2 can gain access to the CNS,12  
and related viruses are thought to enter the brain via the olfactory bulb with spread to the thalamus 
and brainstem. Indeed, it has been postulated that brainstem involvement may contribute to 
respiratory failure in some patients with COVID-19.13 However, at the time of writing, only two cases 
of rhomboencephalitis have been described in association with COVID-19. One had MRI findings 
consistent with rhomboencephalitis but normal CSF and improved rapidly with supportive therapy.14 
The second was thought most likely to be in keeping with a post-infectious syndrome having 
presented with a brainstem syndrome including hyperekplexia, and normal MRI and CSF and was 
treated with corticosteroids with rapid improvement.15  
 
Other infectious causes 
 
Multiple additional viral infections have been reported to cause rhomboencephalitis although these 
are more likely to occur in children.  
 
Enterovirus-71 (EV71) is the second most common infective cause of rhomboencephalitis overall, 
but predominantly affects those <5 years of age.16 Outbreaks have tended to occur in the Asia-
Pacific region,  with transmission via airborne droplets or faeco-oral route. It is a recognised cause of 
hand foot and mouth disease but, in severe cases, can cause an acute, polio-like, flaccid paralysis, 
aseptic meningoencephalitis and rhomboencephalitis. In adults, neurological complications are 
uncommon.  
 
Other infectious aetiologies include Japanese encephalitis (JE), Epstein-Barr virus (EBV) and 
cytomegalovirus (CMV). In the unvaccinated, JE tends to affect young adults and children exposed to 
animals including pigs which carry the virus transmitted from the Culex mosquito around the Pacific 
rim, eastern and southern Asia. Patients with JE have been reported to have transient parkinsonian 
features with ‘dull, flat, mask-like facies with unblinking eyes’, although tremor is not commonly 
reported and hypophonia may be marked.  MRI-brain characteristically shows high T2 signal within 
the thalamus, brainstem and basal ganglia and is thereby distinct from the typical appearances of 
HSV encephalitis.17 
 
EBV encephalitis predominantly affects children, although cases in adults are well-recognised.18 EBV 
encephalitis may affect the temporal lobes, masquerading as HSVE, but can also damage the 
diencephalon or, less frequently, cause rhomboencephalitis. Features suggesting infection with EBV 
include cervical lymphadenopathy, hepatosplenomegaly and transaminitis.  
 
CMV encephalitis should be suspected in immunodeficient patients with an EBV-like constellation of 
symptoms, transaminitis, diarrhoea, retinitis, pneumonia or painful ulcers in the oesophagus or 
intestine. It can lead to direct damage of the brainstem through CMV inclusions and microglial 
nodules.19 Importantly, both EBV and CMV can lead to perivascular lymphocytic infiltration with 
oedema and glial nodules due to Bickerstaff’s brainstem encephalitis (BBE).  
 
Para-infectious 
Bickerstaff’s brainstem encephalitis 
 
Typically, BBE is a monophasic, post-infectious syndrome involving a triad of ophthalmoplegia, 
ataxia, and depressed level of consciousness. Electroencephalogram (EEG) abnormalities are 
common and, although MRI brain is usually normal, it can show scattered T2 hyperintensities in the 
brainstem and basal ganglia with limited enhancement and mild diffusion restriction.20 In contrast to 
Miller-Fisher syndrome (MFS) and Guillain-Barre syndrome (GBS), BBE is associated with 
hyperreflexia. However, peripheral motor axonal neuropathy and detection of anti-GQ1b antibodies 
have been reported in approximately two-thirds of patients with BBE. Intravenous immunoglobulin 
(IVIg) and/or plasma exchange may be considered in an attempt to expedite recovery although, 
overall, the prognosis is relatively favourable; a retrospective analysis of 62 cases reported 66% 
complete remission at 6 months.21  
 
Acute disseminated encephalomyelitis  
 
Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory disorder of the CNS causing 
destruction of myelin and cerebral white matter. Although more common in children, ADEM is well-
recognised in adults. Patients may present 1-3 weeks after a viral prodromal illness or vaccination 
and symptoms can include a combination of fever, ataxia, confusion, seizures and/or coma. 
Characteristically, ADEM is a monophasic illness which progresses over days before reaching a 
plateau although relapse is reported in a minority of patients and a rare, fulminant form, known as 
acute haemorrhagic leukoencephalitis (AHLE) (Figure 3), is also recognised.22  
 
The pathophysiology of ADEM is not fully understood but cell-mediated or antibody cross-reaction 
with myelin autoantigens are thought to occur in response to an environmental trigger or increased 
CNS vascular permeability due to inflammation post-vaccination or infection. Putative causative 
organisms include several viruses directly linked to rhomboencephalitis such as EBV, CMV, HSV, 
Human Herpes Virus 6 (HHV-6).  
 
Typical MRI findings in ADEM include fleeting multi-focal asymmetrical white matter T2 and fluid-
attenuated inversion recovery (FLAIR) hyperintensities with ‘open-ring’ contrast enhancement but 
no central restriction on diffusion-weighted imaging.23 This has been said to have a ‘grass-fire 
appearance’ with relatively less mass effect than might be expected given the lesion size. 
Involvement of the thalami, brainstem (Figure 3) and cerebral cortex may aid radiological 
differentiation from MS.23 Initial treatment for ADEM is with intravenous methylprednisolone 1g 
over 3-5 days followed by plasma exchange or IVIg (0.4g/kg/day for 5 days) in steroid refractory 
cases. Cyclophosphamide can also be considered in fulminant ADEM. Oral steroids should be 
tapered over 6 weeks and vaccinations avoided for 6 months following treatment. Decompressive 




Paraneoplastic antibodies have been well-documented to cause rhomboencephalitis and discovery 
of new cell surface autoantibodies and characterisation of their respective clinical phenotypes is a 
rapidly expanding field. Table 2 lists paraneoplastic antibodies reported to be associated with 
rhomboencephalitis, tumour associations and treatment options. 
Table 2 – Paraneoplastic antibodies associated with rhomboencephalitis 
Antigen 
Location 
Antibody Oncological Association Treatment 
Intracellular Anti-Hu (ANNA-1) Small-cell lung cancer Cancer targeted 
therapy +/- 
immunosuppression* 
 Anti-Ri (ANNA-2) Breast, lung Cancer targeted 
therapy +/- 
immunosuppression 
 Anti-Ma2 Testicular germ cell tumour Cancer targeted 
therapy +/- 
immunosuppression 






cell lung cancer and Hodgkin’s 
lymphoma (anti-Yo); Hodgkin’s 
lymphoma (anti-Tr); breast and 





Cell Surface Anti-NMDA Ovarian teratoma Immunosuppression 
+/- cancer targeted 
therapy 
 Anti-IgLON5 None currently Immunosuppression 
 Anti-glycine receptor  Breast, thymoma, Hodgkin’s 
lymphoma 
Immunosuppression 
+/- cancer targeted 
therapy 
 Less common: anti-
DPPX 
Lymphoma Immunosuppression +/- 
cancer targeted 
therapy 
*Immunosuppression is usually with high dose steroids and either intravenous immunoglobulin 
(IVIg) or plasma exchange first line followed by rituximab or cyclophosphamide.  ANNA = anti-
neuronal nuclear antibody, DPPX = dipeptidyl-peptidase–like protein 6, IgLON5 = immunoglobulin-
like cell adhesion molecule 5, NMDA = N-methyl-D-aspartate 
Cell surface antibodies 
Anti-NMDA receptor encephalitis 
 
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common autoimmune cell 
surface-mediated encephalitis. It is characterised by a combination of dysautonomia, seizures, 
movement disorders and psychiatric symptoms. It is often associated with malignancy, particularly 
ovarian teratomas, but has also been described following HSV and varicella zoster virus 
encephalitis.25 26 
 
Anti-NMDAR encephalitis has been associated rarely with rhomboencephalitis in adults although this 
appears to be a more frequent manifestation in the paediatric population. Despite the marked 
clinical features, brain MRI can frequently be normal and is recognised as a clinical-radiological 
paradox. However, T2 hyperintensities in the brainstem, mesial temporal lobes and posterior 
periventricular white matter with cranial nerve enhancement have been reported.27 Paired serum 
and CSF antibody testing is recommended.  
 
First-line treatment for NMDAR encephalitis is high dose steroids followed by IVIg or plasma 
exchange and escalation to cyclophosphamide or rituximab and/or introduction of a steroid-sparing 
agent as required. There may be clinical uncertainty whilst waiting for antibody test results but there 
is emerging evidence to support use of IVIg in some forms of encephalitis. Indeed, the question of 
whether there may be a role for prophylactic immunosuppression in HSVE patients to prevent 
development of secondary NMDAR antibodies has been raised,26 and a UK-based, double-blinded 
randomised trial is currently underway to determine whether IVIg improves outcomes in children 
with infective or immune-mediated encephalitis (IgNiTE; ISRCTN15791925).  
 
Immunoglobulin-like cell adhesion molecule 5 (IgLON5) receptor encephalitis 
 
IgLON5 receptor is a neuronal cell adhesion protein of uncertain physiological function. Antibodies 
against IgLON5 trigger deposition of tau in the hypothalamus and tegmentum and are associated 
with HLA-DRB1*1001 and HLA-DQB1*0501.  IgLON5 receptor encephalitis was first described in 
2014 as a disorder of sleep, brainstem and hypothalamic function, movement (particularly chorea), 
cognition and a progressive supranuclear palsy-like syndrome. Typically, brainstem involvement 
causes bulbar dysfunction manifesting as dysphagia, sialorrhea, stridor or acute respiratory 
insufficiency. A retrospective analysis of 22 patients with anti-IgLON5 antibodies reported 81.8% had 
normal/non-specific brain MRI changes with mild brainstem and hippocampal atrophy in 13.7% and 
4.5% respectively.28 CSF was unremarkable with 50% showing only a mildly raised protein. Outcome 
was poor; 59% died of respiratory complications.  
 
 Anti-IgLON5 disease should be considered in rhomboencephalitis presenting on the background of 
sleep disorder, chorea, bulbar dysfunction or central hypoventilation. Early treatment with 
immunotherapy may prevent life-threatening acute respiratory failure and/or avoid further 
unnecessary investigations.29 
 
Progressive encephalomyelitis with rigidity and myoclonus (PERM) 
 
PERM is characterised by painful spasms, autonomic dysfunction, hyperekplexia, brainstem 
myoclonus and breathing problems;30 it has been labelled ‘stiff-person syndrome-plus’ given the 
additional brainstem abnormalities. It has only recently been associated with anti-glycine receptor 
(anti-GlyR) antibodies and the clinical phenotype in the largest retrospective cohort of 52 patients 
included hyperekplexia, stiffness/spasms/rigidity, oculomotor disturbance and facial/bulbar motor 
involvement. This was followed by seizures, encephalopathy and cognitive defects. Respiratory 
failure occurred in 27%.30 Brain MRI findings were relatively non-specific although a minority 
demonstrated bilateral temporal lobe hyperintensities. Continuous motor activity may be seen on 
electromyography (EMG) and 6/29 showed spontaneous or stimulus-induced activity. CSF 
pleocytosis is typical and unmatched oligoclonal bands may be present. 
 
Anti-GlyR antibodies should be requested in the serum and CSF in patients with suspected stiff-
person syndrome and evidence of brainstem dysfunction. CSF antibody testing can be helpful when 
serum anti-GlyR antibodies are low (<1:20 dilution) and discussion with specialist neuro-immunology 
laboratories is encouraged. PERM has been associated infrequently with other antibodies including 





Anti-Hu (anti-neuronal nuclear antibodies-1; ANNA-1) antibody is most commonly associated with 
small cell carcinoma which targets the cell nucleus. In 15% of patients it occurs secondary to an 
extra-thoracic malignancy.  In the context of rhomboencephalitis, it preferentially affects the 
medulla causing dysphagia, dysarthria and central hypoventilation.  In contrast, anti-Ma2 
paraneoplastic syndrome typically affects the mesencephalon causing a vertical gaze palsy and being 
associated with T2-hyperintensities in the superior colliculi or periaqueductal grey region.32 These 
features, particularly if accompanied by malignancy or risk factors including smoking, should raise 
the possibility of a paraneoplastic syndrome (PNS) rhomboencephalitis. Importantly, the PNS 
commonly precedes other clinical manifestations of malignancy, and if a cancer is not initially 
detected, ongoing screening is required for a minimum of 5 years.  
 
CSF interrogation in PNS may yield a mild pleocytosis, but extended immunoblotting screens are 
usually required to search for all additional or atypical anti-neuronal antibodies in both serum and 
CSF. Of the three most common neuronal antibodies linked to rhomboencephalitis (anti-Hu, anti-Ri 
and anti-Ma2), anti-Ma2 has the most favourable prognosis following combination immunotherapy 





Although diagnostic criteria are available, the diagnosis of Behçet’s disease can be challenging (Table 
3). Careful questioning regarding recurrent oro-genital ulceration and symptoms of iritis or erythema 
nodosum are necessary. Pathergy testing and HLA-B51 allele screening may be required. Retinal 
angiography is also recommended to look for retinal vasculopathy which is easily overlooked on 
routine ophthalmological examination. 
 
Manifestations of neuro-Behçet’s can be divided into a CNS inflammatory parenchymal disease with 
predilection for the corticospinal, spinothalamic and posterior column tracts and a non-parenchymal 
vascular form which typically presents as dural venous sinus thrombosis.  
 
Radiologically, neuro-Behçet’s favours the brainstem although may sometimes affect the 
diencephalon but the mechanism behind this predilection is unclear.33 Acutely, T2- and FLAIR-
weighted hyperintensities with corresponding hypo-/isointensities on T1 sequences predominate 
with patchy T1-gadolinium enhancement (Figure 5). A longitudinal myelitis-like, inflammatory lesion 
can be seen extending to the brainstem giving a distinct appearance known as the ‘bagel sign’ due to 
venous engorgement and/or acute blood products. Occasionally, brainstem and subcortical lesions 















Table 3: International Study Group for Behçet’s Disease Classification criteria. A definite 
diagnosis requires recurrent oral ulceration with at least two of the other findings in the 
absence of other clinical explanations. 
Finding Definition 
Recurrent oral ulceration Minor aphthous, major aphthous, or 
herpetiform ulcers observed by the physician or 
reliably described by the patient which 
recurred at least three times over a twelve-
month period 
Recurrent genital ulceration Aphthous ulceration or scarring observed by 
the physician or reliably described by the 
patient 
Eye lesions Anterior or posterior uveitis or cells in the 
vitreous body on slit-lamp examination, or 
retinal vasculitis detected by an 
ophthalmologist 
Skin lesions Erythema nodosum, pseudofolliculitis, 
papulopustular lesions, or acneiform nodules 
not related to glucocorticoid treatment or 
adolescence 




Systemic lupus erythematosus  
 
Systemic lupus erythematosus (SLE) is a multi-system autoimmune disorder. ‘Neurolupus’ has 
myriad clinical manifestations including seizures, myelopathy, strokes, aseptic meningitis, psychosis 
and unexpected movement disorders including myoclonus and parkinsonism.34 A prospective study 
of 7 patients with SLE-induced rhomboencephalitis reported headache, vertigo and reduced level of 
consciousness as the most common clinical features.35 Microvasculopathy leads to ischaemia, 
antibody-mediated cell injury and cytokine-induced blood brain barrier permeability allowing 
leukocyte translocation and inflammation.  
 
Radiologically, CNS lupus typically causes subcortical and periventricular white matter changes on 
MRI with diffuse T2 and FLAIR hyperintensities within the deep white matter, brainstem and 
cerebellum.35 Brainstem involvement is rare in SLE, although concomitant periventricular lesions 
necessitate consideration of the diagnosis.  
 
Other demyelinating conditions 
 
 
A number of demyelinating conditions may be associated with inflammatory brainstem lesions such 
as ADEM (discussed previously), multiple sclerosis (MS) and neuromyelitis optica spectrum disorder 
(NMOSD) including anti-myelin oligodendrocyte (MOG) and anti-aquaporin-4 (AQP4) antibodies.  
 
An area postrema syndrome may occur with clinical features such as intractable hiccups, nausea and 
vomiting which may appear in isolation or together with optic neuritis and myelitis to suggest 
neuromyelitis optica (NMO). NMO typically favours the dorsal region of the medulla and pons 
surrounding the fourth ventricle. Additional clues suggesting anti-MOG disease include an ADEM-like 
presentation, bilateral optic nerve involvement, cortical encephalitis and/or the presence of ‘fluffy’ 
brainstem appearances (30%).36 Serological testing confirms the diagnosis with no current evidence 
for improved sensitivity with CSF testing suggesting predominantly extrathecal production.   
 
Mimics 
An awareness of the radiological mimics of rhomboencephalitis is important (Table 4 and Figure 6). 
The most common differential diagnosis is a primary intracerebral malignancy, particularly glioma. 
Additional investigations may therefore include CSF cytology and flow cytometry (assuming safe to 
proceed with lumbar puncture) and MR spectroscopy which may demonstrate raised choline/NAA 
(n-acetylaspartate) ratio suggestive of malignancy.  
  
Table 4 – Rhomboencephalitis Mimics 
Intra-axial neoplasms – primary intracerebral malignancy, CNS lymphomas, metastases 
Tumefactive demyelination 
Vascular: brainstem stroke, vasculopathies and advanced small vessel ischaemic changes 
Central pontine myelinolysis or osmotic demyelination syndrome (ODS) 




Toxins – heroin-induced leukoencephalopathy, cocaine abuse, methylbromide, carbon monoxide 







Key points to explore when taking a history of rhomboencephalitis include the following: 
• A febrile illness may suggest infectious pathology (See Table 5) 
• Enquiring about recreational drug use, particularly cocaine which can erode the surrounding 
skull base and sinuses creating a pathway from the nasal cavity to the brainstem 
• Smoking history to assess the risk of PNS 
• ‘B’ symptoms (fever, weight loss and night sweats) which could indicate an underlying 
lymphoma or TB 
• A gynaecological history including post-menopausal bleeding/discharge, menstrual cycle 
changes, pelvic pain or bloating which may be associated with an underlying malignancy 
•  Outcomes of breast examinations/screening in females should be explored 
•  Males should be asked about testicular self-examination findings and investigated 
accordingly  
• Sleep disorders such as obstructive sleep apnoea or parasomnias may suggest anti-IgLON5 
disease 
• Connective tissue disease symptoms should be probed including: mouth/genital ulcers, 
rash, arthralgias/myalgias, xerostomia/xerophthalmia, symptoms of iritis or serositis, 
Raynaud’s and photosensitivity 
• Discrete neurological relapses including features of myelitis or optic neuritis may suggest 






Table 5 – Practical approach to history taking in infective rhomboencephalitis 
Specific Questions Infective Agent 
Have you consumed any unpasteurised cheeses or 
milks, cured meats, pâtés, smoked fish, cooked 
shellfish or non-supermarket ice creams recently? 
Listeria monocytogenes or brucellosis 
Are you taking any medications to suppress your 
immune system? 
All but particularly HHV-6 (human herpes virus-6) 
and Listeria monocytogenes 
Travel history: 
- Travel destination (including rural/urban) 
- Reason for traveling 
- Travel dates and time from returning to 
symptoms 
- Sexual history, including HIV risk factors and 
recreational drugs 
- Pre-travel vaccinations and prophylaxis 
- Animal contact (especially pigs, bats, dogs, 
cats) and mosquito/tick bites 
- Fresh water contact 
- Japanese encephalitis (Pacific rim, eastern 
and southern Asia) 
- Enterovirus-71 (Asian-Pacific countries) 
- Scrub typhus (Southeast Asia, Indonesia, 
China, Japan, India, and northern Australia) 
- West Nile virus (Africa, the Middle East, 
Asia and Australia) 
- Rabies encephalitis (All continents except 
Antarctica)  
Any unwell contacts? Any children with viral 
infections including hand, foot and mouth? 
Enterovirus-71 
Any recent mouth or genital ulcers? HSV-1 and HSV-2 (note Behçet’s or SLE can cause 
ulcers) 
Any recent sore throats or neck swelling? EBV and CMV 
Any diarrhoea, pain on swallowing (suggesting 
oesophageal ulcers), blurred or loss of night vision 





A complete systemic and neurological examination is required with attention paid to the following: 
 
• Fever and lymphadenopathy may suggest infective causes such as EBV/CMV or an 
underlying malignancy/PNS 
• Mouth/genital ulcers could suggest HSV, Behçet’s or SLE 
• Inspection of the nasal passage may reveal erosions suggesting portal of entry for infection 
• Autonomic dysfunction (systolic blood pressure drop ≥20mmHg on standing, resting 
tachycardia, constipation and/or urinary retention) may suggest a cell surface-mediated 
PNS 
• Movement disorders including orofacial dyskinesias, dystonias, chorea and stereotypies 
could suggest anti-NMDA receptor encephalitis or Japanese encephalitis. 
• Breast examinations and testicular examinations should be carried out in females and males 
respectively to look for underlying malignancies  
• Vertical gaze palsy may be associated with anti-Ma2 antibodies but, in combination with 
features of parkinsonism, could suggest anti-IgLON5 disease 
• Hyperekplexia in response to auditory or tactile stimulation with rigidity (predominantly 
axial) may be a feature of PERM 
• Skin changes such as erythema nodosum, butterfly/discoid rash, or pseudofolliculitis 
suggest autoimmune causes 
 
Investigation and Management 
 
Management of rhomboencephalitis is tailored to the cause although it may be pragmatic to 
consider broad spectrum anti-microbials including viral and listeria cover in all cases presenting 
acutely or sub-acutely with rhomboencephalitis pending initial investigation results. Table 6 










Table 6 – Investigations to consider in rhomboencephalitis 
Infectious 
Blood 
Blood serology and/or polymerase chain reaction (PCR) (see Table 1 for full aetiological agents) 
Blood cultures (bacterial infections including listeria) 
Cerebrospinal fluid (CSF) 
Microscopy, culture & sensitivity for listeria, TB and others (see Table 1) 
Standard viral PCR and EBV/CMV/HHV-6 /TB PCR if immunocompromised or on clinical suspicion 
Consider Whipple disease polymerase chain reaction 
Consider bacterial 16S rDNA real-time PCR for a broad bacterial screen 
Other  
Stool cultures/rectal swabs (enterovirus-71) 
Nasal/throat swabs (viruses including SARS-CoV-2, enterovirus and influenza) 
Sputum sample or early morning urine for TB microscopy, culture and sensitivity 
†If recent exotic foreign travel or atypical presentation discuss with infectious disease team or microbiology for 
rarer infections 
Paraneoplastic 
Intracellular antibodies  
Anti-Hu, anti-Ri, anti-Ma2, anti-Yo, anti-Tr, anti-amphiphysin and anti-GAD65 
Cell surface antibody 
Anti-NMDA, anti-IgLON5, anti-glycine and anti-DPPX 
Searching for the underlying malignancy 
Lactate dehydrogenase and blood film 
Serum -fetoprotein or -human chorionic gonadotrophin  
CSF cytology and flow cytometry (ideally obtain 10mls) 
Imaging as appropriate including: ultrasound ovaries/testes, MRI pelvis, chest X-ray, mammogram, CT 
chest/abdomen/pelvis or CT-PET.  
Rheumatological 
Autoimmune profile 
Anti-nuclear antibody, complements, anti-double-stranded DNA, extractable nuclear antigen, lupus anticoagulant 
(not if on anticoagulation), anti-cardiolipin and anti-beta2-glycoprotein-1 
Sarcoidosis 
Serum/CSF angiotensin converting enzyme, CSF soluble interleukin-2 and chest imaging 
Neuro-Behçet's syndrome  
HLA-B51, retinal fluorescein angiography/indocyanine green angiography, skin biopsy and pathergy test  
Sjögren’s syndrome  
Schirmer’s test, salivary gland/mucosal lip biopsy or technetium-99m scialoscintigraphy 
Para-infectious 
Acute disseminated encephalomyelitis 
Anti-MOG antibodies  
Bickerstaff’s brainstem encephalitis 
Ganglioside antibodies including anti-GQ1b 
If ongoing diagnostic uncertainty, consider brain biopsy 
  
Biopsy and other neurosurgical interventions 
 
Brain biopsy, particularly in the brainstem, has been considered a high-risk procedure. However, 
emerging data suggest that safety has improved and brainstem biopsy can have considerable clinical 
utility in selected cases, particularly where malignancy is considered in the differential diagnosis or 
there is ongoing diagnostic uncertainty.37 38  The risk of the procedure needs to be weighed against 
the benefit of diagnostic clarity, treatment optimisation and avoidance of iatrogenic harm e.g. due 
to unnecessary immunosuppression. Where there is diagnostic uncertainty in a rapidly deteriorating 
patient, we recommend early discussion with neurosurgical colleagues to consider a biopsy, 
particularly where a target lesion is identified.39  
 
Urgent repeat neuroimaging is indicated if a patient with a known brainstem syndrome develops 
new signs or reduced level of consciousness. Complications including hydrocephalus or haemorrhage 
may warrant neurosurgical management.6 This is particularly relevant where the underlying cause of 




Rhomboencephalitis is an uncommon neurological condition with potentially devastating sequelae, 
particularly if left untreated. A structured and pragmatic approach when faced with this neurological 
challenge is therefore required. A careful and complete assessment of the history together with 
systemic and neurological examination are crucial to guide prompt initiation of appropriate 
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Key points 
 Rhomboencephalitis typically presents with encephalopathy  long tract signs, 
cranial nerve deficits and/or cerebellar dysfunction 
 Suspected infection should prompt enquiry about snorting cocaine which can 
create an artificial portal of entry 
 The most common cause is listeria and early, empirical treatment should be 
considered 
 Specialist review of MRI-brain scans can refine the differential diagnosis 
 Neurosurgical intervention including diagnostic biopsy and emergency treatment 
of hydrocephalus may be required 
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Figure 1 – The rhombencephalon 
Sagittal MRI-brain demonstrating the anatomy of the rhombencephalon or hindbrain. Highlighted 
structures include the pons (blue), medulla (red), cerebellum (green) and the mid-region of the 
fourth ventricle (orange). 
 
Figure 2 – Listeria rhomboencephalitis 
Sagittal T1-weighted MR brain scan reproduced with permission from Abbs et al Practical Neurology 
2012;12:131-132 
 
Figure 3 - Acute haemorrhagic leucoencephalitis 
MRI brain T2WI (sagittal image) showed extensive brainstem involvement with hyperintense signal, 
reproduced with permission from Nabi et al, BMJ Case Reports 2016;2016:bcr2016217215 
 
Figure 4 Seronegative autoimmune encephalitis 
A & B) Axial T2 and Coronal FLAIR MRI demonstrating abnormal hyperintense signal in the pons, 
midbrain and also bilaterally within the hippocampi. C) Axial Post-Gd T1 MRI with patchy pontine 
enhancement (white arrow). D & E) Follow-up Axial T2 and Sagittal T1 MRI performed 22-months 
after first presentation demonstrating marked pontine atrophy (arrowhead) with bilaterally 
symmetrical linear hyperintensity within the pontocerebellar fibres (dotted arrows)  
 
Figure 5 – Parenchymal brainstem neuro-Behçet’s syndrome 
Brain MRI shows lesions in the pons extending to bilateral middle cerebellar peduncles, which are 
hypointense on T1-weighted imaging (A), hyperintense on T2-weighted imaging (B), with 
heterogeneous contrast enhancement (C) reproduced with permission from Yildiz et al BMJ Case 
Reports 2013;2013:bcr2013200738 
 
Figure 6 – Rhomboencephalitis mimics 
A) Lymphoma:  Coronal FLAIR MRI - Abnormal signal hyperintensity demonstrated within the vermis 
and left paramedian vermis with minimal local mass effect. Lesion demonstrates abnormal restricted 
diffusion and homogenous enhancement (not shown) as expected in primary CNS lymphoma 
B) Astrocytoma: Coronal T1 Post-Contrast MRI - Irregular peripherally enhancing and centrally 
necrotic lesion in the lower pons/upper medulla. Mild local mass effect with expansion of the 
involved structures. 
C) and D) Osmotic demyelination syndrome: C) Axial Non-Contrast CT Head – Spherical hypodensity 
involving the central pons which is mildly expanded. D) Axial T2 – Well demarcated central pontine 
T2 hyperintensity with sparing of the periphery and the descending corticospinal tracts (white 
arrows) 
E) and F) CLIPPERS: E) Axial T2 MRI – florid patchy and linear punctate hyperintensities 
demonstrated within the brainstem and bilaterally in the cerebellum with no associated oedema or 
local mass effect (white arrows). F) Sagittal T1 post contrast MRI Brain and upper cord – numerous 
enhancing punctate foci in the brainstem, cerebellum and the upper cervical spinal cord. 
 
